Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Methanex Corporation (MEOH.O)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date	Stock Price (US$)	Price Target (US$)	Rating
2022-02-15	50.01	35.00	Sell
2022-04-07	55.15	44.00	Sell
2022-07-12	36.05	36.00	Sell
2022-07-27	39.61	34.00	Sell
2022-10-11	33.56	31.00	Sell
2023-02-02	47.21	41.00	Sell
2023-04-11	44.97	39.00	Sell
2023-04-26	42.97	40.00	Sell
2023-07-11	42.70	38.00	Sell
2023-07-26	44.00	37.00	Sell
2023-10-09	45.03	40.00	Sell
2023-11-01	41.91	45.00	Neutral
2023-12-13	44.05	48.00	Neutral
2024-01-10	44.94	51.00	Neutral
2024-02-07	44.94	60.00	Buy
2024-04-08	49.91	59.00	Buy
2024-04-24	47.71	62.00	Buy
2024-04-29	50.40	60.00	Buy
2024-06-05	50.50	62.00	Buy
2024-07-09	47.31	64.00	Buy
2024-07-30	46.68	62.00	Buy
2024-08-20	44.46	58.00	Buy
2024-09-16	38.62	54.00	Buy
2024-11-06	38.97	53.00	Buy
2025-02-06	50.96	66.00	Buy
2025-04-07	27.39	53.00	Buy
2025-04-30	31.29	51.00	Buy
2025-05-12	34.48	50.00	Buy

Disclosures

UBS Securities LLC makes a market in the securities and/or ADRs of this company.
UBS holds a long or short position of 0.5% or more of the listed shares of this company.

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.